Adaptive Biotechnologies Corporation (ADPT) stock analysis
ADPT · Adaptive Biotechnologies Corporation
Latest recorded price: USD 27.87
Sector and industry: Healthcare · Diagnostics & Research
Fiscal 2025 figures: revenue growth 14.3%, free cash flow margin -17.7%. The model flags 2 risk signals for this company (1 high severity).
Similar companies in Healthcare
- CareDx, Inc. - Common Stock (CDNA)
- Charles River Laboratories International, Inc. (CRL)
- Castle Biosciences, Inc. (CSTL)
- Quest Diagnostics Incorporated Common Stock (DGX)
- Danaher Corporation Common Stock (DHR)
- Guardant Health, Inc. (GH)
- IDEXX Laboratories, Inc. - Common Stock (IDXX)
- Illumina, Inc. - Common Stock (ILMN)